Iraq is one of the fastest growing economies in Middle East and North Africa (MENA) attributed by the flourishing oil sector that is helping the domestic government to improve health care services. The Iraq health care system is managed by mixed initiatives of public and private sector; wherein the public sector covers approximately 75% of all health care facilities, and the private sector represents the remaining 25%. Iraq has improved its health care system after years of war. The booming petroleum industry is helping the Government of Iraq to invest in improving health care services and develop medical infrastructure. Furthermore, the burden of non-communicable diseases is increasing significantly, which has created a significant demand for medical equipment and services in Iraq. This industry assessment focuses on understanding the growth prospects and current situation of various surgical procedures that are major applications of medical devices.

Among the major surgical procedures considered to be performed in the country, that include cardiac procedures, general surgeries, orthopedic surgeries, neurosurgeries and reconstructive surgeries; cardiac procedures emerged as the segment leader in terms of revenue in 2013. The substantiating factors behind such rapid growth of the segment are rise in prevalence of diabetes population susceptible to cardiovascular diseases and increasing base of target patient population requiring surgical procedures for their survival. According to the Iraqi Diabetes Association (IDA), there were around 1.2 million cases of diabetes in Iraq in 2014. Approximately 387 million people suffer from diabetes globally, of these more than 37 million people are from MENA. IDA also estimated that this number would increase to 68 million by 2035. Consequently, the rise in prevalence of diabetes population would lead to increase in cardiovascular diseases in Iraq. Other risk factors associated with cardiovascular diseases such as early onset hypertension, dyslipedemia, and obesity also contribute significantly towards increasing the overall CVD burden in Iraq. Thus, with the increase in number of cardiovascular patients and stable industry condition in Iraq, the flourishing healthcare industry trend of the country is expected to continue in the near future. 

Iraq healthcare industry is highly fragmented in nature, due to the presence of many international as well as domestic market players including distributors. However, few multinational market players such as Siemens Healthcare, Phillips Healthcare, and Medtronic plc, among others dominate the medical device industry in Iraq. Other players (including manufacturers and distributors) operating in the industry include Rudolf Riester GmbH, Minas Company, Ismailiya Medical Co., Albanna Group, GE Healthcare, MAQUET and Stryker Corporation; that cumulatively accounted for a share of over 40% in 2013. The market leadership of such players was attributed to several factors such as commercial availability of products, superior distribution channels, and demand satisfying supply capabilities. 

 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Iraq Healthcare (Surgical Procedures) Industry Assessment
 
Chapter 3 Iraq Healthcare (Surgical Procedures) Industry Overview
3.1 Industry Dynamics and Overview
3.2 Drivers
      3.2.1 Lucrative Government Healthcare Spending Expected to Accentuate the Industry Growth
      3.2.2 Increasing Burden of Non-communicable Diseases (such as Diabetes, Hypertension, Cancer and CVD) is Likely to Boost Demand for Health Care Facilities and Related Solutions
      3.2.3 Booming Oil Industry is Fueling Health Care Investments in Iraq
3.3 Restraints
      3.3.1 Undeveloped Infrastructure (Including Unequipped Banking System) could Hinder Market Growth
      3.3.2 Security Concerns and Frequent Political Unrest Prevent Foreign Investments, thus Restraining Market Growth
3.4 Opportunities
      3.4.1 Initiatives for Joint Business Ventures and Collaborative Agreements
      3.4.2 Explore Avenues for Introduction of Refurbished Equipment
3.5 Government Involvement and Regulatory Framework: Iraq Healthcare Industry
      3.5.1 Regulatory Bodies
              3.5.1.1 Ministry of Health (MoH):
              3.5.1.2 Medicines Regulatory Authority (MRA) in Iraq:
      3.5.2 Functioning of the Government Bodies on the Medical Device and Pharmaceutical Business Dynamics in Iraq
              3.5.2.1 Medical Devices
              3.5.2.2 Pharmaceuticals
3.6 Market Share Analysis: Iraq Healthcare Industry (Medical Device Manufacturers and Distributors), by Key Players, 2013 (Value %)
 
Chapter 4 Iraq Healthcare (Surgical Procedures) Industry Assessment, by Segments (Surgical Procedures)
4.1 Overview
      4.1.1 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by Segments, 2012 – 2022 (USD Million)
4.2 Cardiac Procedures
      4.2.1 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by Cardiac Procedures, 2012 – 2022 (USD Million)
4.3 General Surgeries
      4.3.1 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by General Surgeries, 2012 – 2022 (USD Million)
4.4 Orthopedic Procedures
      4.4.1 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by Orthopedic Procedures, 2012 – 2022 (USD Million)
4.5 Neurosurgeries
      4.5.1 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by Neurosurgeries, 2012 – 2022 (USD Million)
4.6 Reconstructive Surgeries
      4.6.1 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by Reconstructive Surgeries, 2012 – 2022 (USD Million)
 
Chapter 5 Recommendations
 
Chapter 6 Company Profiles
6.1 Al Assad Scientific Bureau
      6.1.1 Company Overview
      6.1.2 Financial Overview
      6.1.3 Product Portfolio
      6.1.4 Business Strategies
6.2 Albanna Group
      6.2.1 Company Overview
      6.2.2 Financial Overview
      6.2.3 Product Portfolio
      6.2.4 Business Strategies
6.3 Applied Medical Corporation
      6.3.1 Company Overview
      6.3.2 Financial Overview
      6.3.3 Product Portfolio
      6.3.4 Business Strategies
6.4 Aesculap, Inc.
      6.4.1 Company Overview
      6.4.2 Financial Overview
      6.4.3 Product Portfolio
      6.4.4 Business Strategies
      6.4.5 Recent Developments
6.5 Ismailiya Medical Co.
      6.5.1 Company Overview
      6.5.2 Financial Overview
      6.5.3 Product Portfolio
      6.5.4 Business Strategies
6.6 Koninklijke Philips N.V.
      6.6.1 Company Overview
      6.6.2 Financial Overview
      6.6.3 Product Portfolio
      6.6.4 Business Strategies
      6.6.5 Recent Developments
6.7 Maquet Holding B.V. & Co. KG
      6.7.1 Company Overview
      6.7.2 Financial Overview
      6.7.3 Product Portfolio
      6.7.4 Business Strategies
      6.7.5 Recent Developments
6.8 Medtronic, Inc.
      6.8.1 Company Overview
      6.8.2 Financial Overview
      6.8.3 Product Portfolio
      6.8.4 Business Strategies
      6.8.5 Recent Developments
6.9 Minas Company (a subsidiary of Goran Group)
      6.9.1 Company Overview
      6.9.2 Financial Overview
      6.9.3 Product Portfolio
      6.9.4 Business Strategies
6.10 Munir Sukhtian Group Company
      6.10.1 Company Overview
      6.10.2 Financial Overview
      6.10.3 Product Portfolio
      6.10.4 Business Strategies
      6.10.5 Recent Developments
6.11 Rudolf Riester GmbH
      6.11.1 Company Overview
      6.11.2 Financial Overview
      6.11.3 Product Portfolio
      6.11.4 Business Strategies
      6.11.5 Recent Developments
6.12 Siemens Healthcare
      6.12.1 Company Overview
      6.12.2 Financial Overview
      6.12.3 Product Portfolio
      6.12.4 Business Strategies
      6.12.5 Recent Developments
6.13 St. Jude Medical, Inc.
      6.13.1 Company Profile
      6.13.2 Financial Overview
      6.13.3 Product Portfolio
      6.13.4 Business Strategies
      6.13.5 Recent Developments
6.14 Stryker Corporation
      6.14.1 Company Overview
      6.14.2 Financial Overview
      6.14.3 Product Portfolio
      6.14.4 Business Strategies
      6.14.5 Recent Developments
6.15 TeknoMed Company
      6.15.1 Company Overview
      6.15.2 Financial Overview
      6.15.3 Product Portfolio
      6.15.4 Business Strategies
List of Tables
 
TABLE 1 Market Snapshot: Iraq Healthcare (Surgical Procedures) Industry Assessment
TABLE 2 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by Segments, 2012 – 2022 (USD Million)
List of Figures
 
FIG. 1 Iraq Healthcare (Surgical Procedures) Industry Assessment
FIG. 2 Iraq Healthcare (Surgical Procedures) Industry Assessment, by Surgical Procedures, 2013 (USD Million)
FIG. 3 Iraq Healthcare (Surgical Procedures) Industry Assessment, Drivers and Restraints
FIG. 4 Relationships in the First Stages of the Procurement Process
FIG. 5 Market Share Analysis: Iraq Healthcare Industry (Medical Device Manufacturers and Distributors), by Key Players, 2013 (Value %)
FIG. 6 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by Cardiac Procedures, 2012 – 2022 (USD Million)
FIG. 7 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by General Surgeries, 2012 – 2022 (USD Million)
FIG. 8 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by  Orthopedic Procedures, 2012 – 2022 (USD Million)
FIG. 9 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by  Neurosurgeries, 2012 – 2022 (USD Million)
FIG. 10 Iraq Healthcare (Surgical Procedures) Industry Assessment, Market Revenue and Forecast, by   Reconstructive Surgeries, 2012 – 2022 (USD Million)
FIG. 11 Aesculap, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 12 Philips Healthcare.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 13 Maquet Holding B.V. & Co. KG: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 14 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 15 Siemens Healthcare: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 16 St. Jude Medical, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 17 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Iraq Healthcare (Surgical Procedures) Market